RxDoctor Payments Data

Steven Beer, MD

Neurological Surgery · Cheyenne, WYNPI 1588633291

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $159,290 of the $167,507 with a category attached, or 95.1%. Alphatec Spine, Inc accounts for 91.7% of it on its own, with 30 other manufacturers making up the rest. Reporting peaked in 2019 at $45,879 and has fallen 76.5% since, to $10,781 in 2025.

$167,507in general payments, 2019–2025

Across 196 payments — averaging $854.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alphatec Spine, Inc$154K
  • Aesculap Implant Systems, LLC$6K
  • International Rehabilitative Sciences, Inc$3K
  • Abbott$845
  • Medtronic$814
  • Johnson & Johnson$613
  • plus $2K from 25 others

What the payments were for

  • Royalty or licence$159,29095%
  • Food & beverage$4,8903%
  • Other$3,3282%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few neurological surgery providers in Wyomingto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$140,351
Medicare patients
142
Services billed
418

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin14$219
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$166

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Cheyenne

See the full list for Wyoming

Where these figures come from

Is this you, or does something look wrong? →